• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白联合甲胎蛋白在肝细胞癌诊断中的准确性:一项荟萃分析。

Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.

作者信息

Li Jinwan, Chen Xiaoli, Dai Meiyu, Huang Shifeng, Chen Jingfan, Dai Shengming

机构信息

Medical Science Laboratory, the Fourth Affiliated Hospital of Guangxi Medical University, No. 1 Liushi Road, Liuzhou city, Guangxi Province 545005, China.

Medical Science Laboratory, the Fourth Affiliated Hospital of Guangxi Medical University, No. 1 Liushi Road, Liuzhou city, Guangxi Province 545005, China.

出版信息

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):543-553. doi: 10.1016/j.clinre.2017.01.010. Epub 2017 Mar 11.

DOI:10.1016/j.clinre.2017.01.010
PMID:28291627
Abstract

OBJECTIVE

Osteopontin (OPN) has been reported as a potential biomarker for diagnosis of hepatocellular carcinoma (HCC) in many inconsistent results. This study demonstrates a systematic meta-analysis for the evaluation on diagnostic accuracy of serum or plasma OPN and alpha-fetoprotein (AFP) alone and combined assays for HCC.

METHODS

Relevant literatures were searched in PubMed up to August 2016. The quality of each study was evaluated by QUADAS-2 (quality assessment for studies of diagnostic accuracy). Statistical analysis was performed by Meta-Disc 1.4 and Stata 12.0. The random-effect models were used to estimate pooled sensitivity, specificity and other diagnostic indicators of OPN and/or AFP in HCC.

RESULTS

A total of 14 case-control literatures (15 studies) met the inclusion criteria in this meta-analysis. The respective pooled diagnostic sensitivity and specificity were 0.71 (95% CI: 0.69-0.74) and 0.80 (95% CI: 0.78-0.82) for OPN; 0.61 (95% CI: 0.58-0.63) and 0.92 (95% CI: 0.91-0.94) for AFP; 0.82 (95% CI: 0.79-0.84) and 0.77 (95% CI: 0.74-0.80) for OPN plus AFP. Their area under the curve (AUC) values were 0.8786, 0.8718 and 0.9005, respectively.

CONCLUSION

Combination of OPN and AFP was better than OPN or AFP alone in diagnosis of HCC.

摘要

目的

骨桥蛋白(OPN)已被报道为肝细胞癌(HCC)诊断的潜在生物标志物,但结果多有不一致。本研究进行了一项系统的荟萃分析,以评估血清或血浆OPN和甲胎蛋白(AFP)单独及联合检测对HCC的诊断准确性。

方法

截至2016年8月在PubMed上检索相关文献。每项研究的质量通过QUADAS - 2(诊断准确性研究的质量评估)进行评估。采用Meta - Disc 1.4和Stata 12.0进行统计分析。随机效应模型用于估计OPN和/或AFP在HCC中的合并敏感性、特异性及其他诊断指标。

结果

本荟萃分析共纳入14篇病例对照文献(15项研究)。OPN的合并诊断敏感性和特异性分别为0.71(95%可信区间:0.69 - 0.74)和0.80(95%可信区间:0.78 - 0.82);AFP的分别为0.61(95%可信区间:0.58 - 0.63)和0.92(95%可信区间:0.91 - 0.94);OPN加AFP的分别为0.82(95%可信区间:0.79 - 0.84)和0.77(95%可信区间:0.74 - 0.80)。它们的曲线下面积(AUC)值分别为0.8786、0.8718和0.9005。

结论

在HCC诊断中,OPN与AFP联合检测优于单独检测OPN或AFP。

相似文献

1
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.骨桥蛋白联合甲胎蛋白在肝细胞癌诊断中的准确性:一项荟萃分析。
Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):543-553. doi: 10.1016/j.clinre.2017.01.010. Epub 2017 Mar 11.
2
Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.骨桥蛋白与甲胎蛋白用于肝细胞癌诊断的比较:一项荟萃分析。
Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):706-14. doi: 10.1016/j.clinre.2014.06.008. Epub 2014 Jul 14.
3
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.甲胎蛋白、Dickkopf-1和骨桥蛋白对肝细胞癌的诊断价值。
Med Oncol. 2015 Mar;32(3):59. doi: 10.1007/s12032-014-0367-z. Epub 2015 Feb 6.
4
Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.血清/血浆骨桥蛋白在肝细胞癌中的预后及诊断意义的Meta分析
J Clin Gastroenterol. 2014 Oct;48(9):806-14. doi: 10.1097/MCG.0000000000000018.
5
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.高尔基体蛋白73与甲胎蛋白联合检测在肝细胞癌中的诊断价值:一项Meta分析
PLoS One. 2015 Oct 6;10(10):e0140067. doi: 10.1371/journal.pone.0140067. eCollection 2015.
6
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.甲胎蛋白、维生素K缺乏诱导蛋白、骨桥蛋白、Dickkopf-1及其联合检测对肝细胞癌的诊断性能
PLoS One. 2016 Mar 17;11(3):e0151069. doi: 10.1371/journal.pone.0151069. eCollection 2016.
7
Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.血浆骨桥蛋白在丙型肝炎病毒相关性肝细胞癌中的诊断意义。
Ann Hepatol. 2011 Jul-Sep;10(3):296-305.
8
Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.评估骨桥蛋白作为埃及慢性丙型肝炎肝硬化患者肝细胞癌生物标志物的研究
Asian Pac J Cancer Prev. 2018 Apr 25;19(4):1021-1027. doi: 10.22034/APJCP.2018.19.4.1021.
9
Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.血清骨桥蛋白及骨桥蛋白启动子多态性在乙型肝炎相关肝细胞癌中的诊断及预后作用
Asian Pac J Cancer Prev. 2015;16(16):7211-7. doi: 10.7314/apjcp.2015.16.16.7211.
10
Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.血浆骨桥蛋白在丙型肝炎病毒相关肝细胞癌诊断中的意义
Arab J Gastroenterol. 2014 Sep-Dec;15(3-4):103-7. doi: 10.1016/j.ajg.2014.08.002. Epub 2014 Sep 22.

引用本文的文献

1
Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis.肝细胞癌中的液体活检:循环肿瘤DNA作为诊断和预后的潜在生物标志物
Curr Oncol Rep. 2025 May 9. doi: 10.1007/s11912-025-01681-3.
2
Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit.血清骨桥蛋白可增强肝细胞癌诊断并预测抗PD-L1免疫治疗疗效。
J Hepatocell Carcinoma. 2025 Apr 13;12:729-745. doi: 10.2147/JHC.S514144. eCollection 2025.
3
Current status and new directions for hepatocellular carcinoma diagnosis.
肝细胞癌诊断的现状与新方向
Liver Res. 2024 Dec 5;8(4):218-236. doi: 10.1016/j.livres.2024.12.001. eCollection 2024 Dec.
4
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis.肝细胞癌的生物标志物:从起源到临床诊断
Biomedicines. 2023 Jun 28;11(7):1852. doi: 10.3390/biomedicines11071852.
5
Infection with Hepatitis B Virus May Increase the Serum Concentrations of Osteopontin.乙型肝炎病毒感染可能会增加骨桥蛋白的血清浓度。
Intervirology. 2021;64(3):126-134. doi: 10.1159/000513687. Epub 2021 Mar 18.
6
Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.用于肝细胞癌转化医学的蛋白质组学分析与人工智能
Biomedicines. 2021 Feb 6;9(2):159. doi: 10.3390/biomedicines9020159.
7
Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.血清Dickkopf-1蛋白诊断肝细胞癌的诊断准确性:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Aug;98(32):e16725. doi: 10.1097/MD.0000000000016725.
8
Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.肝细胞癌早期检测的生物标志物开发:现状与未来展望
Hepat Oncol. 2017 Oct;4(4):111-122. doi: 10.2217/hep-2017-0019. Epub 2017 Nov 17.